| Acinetobacter baumannii |
Acinetobacter baumannii |
Inhibition |
25.21 |
% |
10.6019/CHEMBL4513141 |
| Bacillus subtilis |
Bacillus subtilis |
Activity |
nan |
None |
10.1021/acs.jmedchem.6b01780 |
| Bacillus subtilis |
Bacillus subtilis |
Inhibition |
nan |
% |
10.1016/j.ejmech.2017.08.039 |
| Candida albicans |
Candida albicans |
Inhibition |
1.72 |
% |
10.6019/CHEMBL4513141 |
| Chlamydia trachomatis |
Chlamydia trachomatis |
Activity |
nan |
None |
10.1016/j.bmcl.2014.06.056 |
| Chlorocebus sabaeus |
Vero |
IC50 |
6.25 |
ug.mL-1 |
10.1016/j.bmcl.2017.05.050 |
| Chlorocebus sabaeus |
Vero |
IC50 |
62.5 |
ug.mL-1 |
10.1016/j.bmcl.2012.12.069 |
| Chlorocebus sabaeus |
Vero |
IC50 |
100.0 |
ug.mL-1 |
10.1021/np400497f |
| Chlorocebus sabaeus |
Vero |
MNCC |
6.25 |
ug ml-1 |
10.1016/j.bmc.2016.09.044 |
| Citrobacter freundii |
Citrobacter freundii |
MIC |
2.0 |
ug.mL-1 |
10.1021/jm00156a021 |
| Cryptococcus neoformans |
Cryptococcus neoformans |
Inhibition |
-5.65 |
% |
10.6019/CHEMBL4513141 |
| Enterobacter cloacae |
Enterobacter cloacae |
MIC |
2.0 |
ug.mL-1 |
10.1021/jm00156a021 |
| Enterococcus faecalis |
Enterococcus faecalis |
MIC |
128.0 |
ug.mL-1 |
10.1128/aac.00166-09 |
| Enterococcus faecalis |
Enterococcus faecalis |
MIC |
128.0 |
ug.mL-1 |
10.1128/aac.00845-07 |
| Enterococcus faecalis |
Enterococcus faecalis |
MIC |
1250000.0 |
nM |
10.1016/j.ejmech.2018.09.067 |
| Enterococcus faecalis (strain ATCC 700802 / V583) |
D-alanine--D-alanine ligase |
IC50 |
262000.0 |
nM |
10.1016/j.ejmech.2018.09.067 |
| Enterococcus faecalis (strain ATCC 700802 / V583) |
D-alanine--D-alanine ligase |
Inhibition |
30.0 |
% |
10.1016/j.ejmech.2018.09.067 |
| Enterococcus faecium |
Enterococcus faecium |
MIC |
64.0 |
ug.mL-1 |
10.1128/aac.00166-09 |
| Enterococcus faecium |
Enterococcus faecium |
MIC |
64.0 |
ug.mL-1 |
10.1128/aac.00845-07 |
| Escherichia coli |
Escherichia coli |
Activity |
0.5 |
None |
10.1128/aac.00845-07 |
| Escherichia coli |
Escherichia coli |
Activity |
5.0 |
None |
10.1128/aac.00845-07 |
| Escherichia coli |
Escherichia coli |
Activity |
nan |
None |
10.1021/acs.jmedchem.6b01780 |
| Escherichia coli |
Escherichia coli |
Activity |
nan |
None |
10.1128/aac.00166-09 |
| Escherichia coli |
Escherichia coli |
Activity |
nan |
None |
10.1128/aac.00845-07 |
| Escherichia coli |
Escherichia coli |
Diameter |
39.0 |
nm |
10.1021/jm00175a002 |
| Escherichia coli |
Escherichia coli |
Inhibition |
1.47 |
% |
10.6019/CHEMBL4513141 |
| Escherichia coli |
Escherichia coli |
MIC |
0.25 |
ug.mL-1 |
10.1021/jm00156a021 |
| Escherichia coli |
Escherichia coli |
MIC |
0.5 |
ug.mL-1 |
10.1021/jm00156a021 |
| Escherichia coli |
Escherichia coli |
MIC |
16.0 |
ug.mL-1 |
10.1016/j.bmcl.2007.01.015 |
| Escherichia coli |
Escherichia coli |
MIC |
16.0 |
ug.mL-1 |
10.1016/j.ejmech.2020.112832 |
| Escherichia coli |
Escherichia coli |
MIC |
16.0 |
ug.mL-1 |
10.1128/aac.00166-09 |
| Escherichia coli |
Escherichia coli |
MIC |
16.0 |
ug.mL-1 |
10.1128/aac.00845-07 |
| Escherichia coli |
Escherichia coli |
MIC |
32.0 |
ug.mL-1 |
10.1021/jm00156a021 |
| Escherichia coli |
Escherichia coli |
MIC |
32.0 |
ug.mL-1 |
10.1128/aac.00166-09 |
| Escherichia coli |
Escherichia coli |
MIC |
32.0 |
ug.mL-1 |
10.1128/aac.00845-07 |
| Escherichia coli |
Escherichia coli |
MIC |
64.0 |
ug.mL-1 |
10.1128/aac.00166-09 |
| Escherichia coli |
Escherichia coli |
MIC |
64.0 |
ug.mL-1 |
10.1128/aac.00845-07 |
| Escherichia coli |
Escherichia coli |
MIC |
128.0 |
ug.mL-1 |
10.1021/jm00156a021 |
| Escherichia coli K-12 |
D-alanylalanine synthetase |
Inhibition |
nan |
% |
10.1038/nchembio.221 |
| Escherichia coli K-12 |
UDP-3-O-acyl-GlcNAc deacetylase |
Inhibition |
nan |
% |
10.1038/nchembio.221 |
| Escherichia coli K-12 |
UDP-N-acetylmuramoyl-tripeptide--D-alanyl-D-alanine ligase |
MIC |
1.0 |
ug.mL-1 |
10.1021/jm00117a017 |
| Escherichia coli K-12 |
UDP-N-acetylmuramoyl-tripeptide--D-alanyl-D-alanine ligase |
MIC |
2.0 |
ug.mL-1 |
10.1021/jm00117a017 |
| Escherichia coli K-12 |
UDP-N-acetylmuramoyl-tripeptide--D-alanyl-D-alanine ligase |
MIC |
4.0 |
ug.mL-1 |
10.1021/jm00117a017 |
| Escherichia coli K-12 |
UDP-N-acetylmuramoyl-tripeptide--D-alanyl-D-alanine ligase |
MIC |
8.0 |
ug.mL-1 |
10.1021/jm00117a017 |
| Escherichia coli K-12 |
UDP-N-acetylmuramoyl-tripeptide--D-alanyl-D-alanine ligase |
MIC |
16.0 |
ug.mL-1 |
10.1021/jm00117a017 |
| Escherichia coli K-12 |
UDP-N-acetylmuramoyl-tripeptide--D-alanyl-D-alanine ligase |
MIC |
32.0 |
ug.mL-1 |
10.1021/jm00117a017 |
| Escherichia coli K-12 |
UDP-N-acetylmuramoyl-tripeptide--D-alanyl-D-alanine ligase |
MIC |
256.0 |
ug.mL-1 |
10.1021/jm00117a017 |
| Escherichia coli (strain K12) |
30S ribosomal protein S18 |
Inhibition |
nan |
% |
10.1038/nchembio.221 |
| Escherichia coli (strain K12) |
Cell division protein FtsA |
Inhibition |
nan |
% |
10.1038/nchembio.221 |
| Escherichia coli (strain K12) |
Iron-sulfur cluster insertion protein ErpA |
Inhibition |
nan |
% |
10.1038/nchembio.221 |
| Escherichia coli (strain K12) |
Outer membrane protein TolC |
Inhibition |
nan |
% |
10.1038/nchembio.221 |
| Escherichia coli (strain K12) |
tRNA threonylcarbamoyladenosine biosynthesis protein TsaE |
Inhibition |
nan |
% |
10.1038/nchembio.221 |
| Homo sapiens |
Acetylcholinesterase |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Adenosine A3 receptor |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Alpha-1a adrenergic receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Alpha-2a adrenergic receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Androgen Receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Bile salt export pump |
IC50 |
1000000.0 |
nM |
10.1124/dmd.111.040758 |
| Homo sapiens |
Bile salt export pump |
IC50 |
1000000.0 |
nM |
10.1124/dmd.112.047068 |
| Homo sapiens |
Bloom syndrome protein |
Potency |
1.1 |
nM |
None |
| Homo sapiens |
Bloom syndrome protein |
Potency |
50118.7 |
nM |
None |
| Homo sapiens |
Chromobox protein homolog 1 |
Potency |
8436.8 |
nM |
None |
| Homo sapiens |
Cyclooxygenase-1 |
AC50 |
19346.4 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Cyclooxygenase-1 |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Cytochrome P450 1A2 |
AC50 |
nan |
None |
None |
| Homo sapiens |
Cytochrome P450 2C19 |
AC50 |
nan |
None |
None |
| Homo sapiens |
Cytochrome P450 2C9 |
AC50 |
nan |
None |
None |
| Homo sapiens |
Cytochrome P450 2C9 |
Potency |
39810.7 |
nM |
None |
| Homo sapiens |
Cytochrome P450 2D6 |
AC50 |
nan |
None |
None |
| Homo sapiens |
Cytochrome P450 3A4 |
AC50 |
10000.0 |
nM |
None |
| Homo sapiens |
Cytochrome P450 3A4 |
AC50 |
12589.25 |
nM |
None |
| Homo sapiens |
Cytochrome P450 3A4 |
AC50 |
31622.78 |
nM |
None |
| Homo sapiens |
Cytochrome P450 3A4 |
AC50 |
nan |
None |
None |
| Homo sapiens |
Cytochrome P450 3A4 |
Potency |
10000.0 |
nM |
None |
| Homo sapiens |
Cytochrome P450 3A4 |
Potency |
12589.3 |
nM |
None |
| Homo sapiens |
Cytochrome P450 3A4 |
Potency |
31622.8 |
nM |
None |
| Homo sapiens |
Cytochrome P450 3A4 |
Potency |
39810.7 |
nM |
None |
| Homo sapiens |
Dopamine D1 receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Dopamine D3 receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Dopamine transporter |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Endoplasmic reticulum-associated amyloid beta-peptide-binding protein |
Potency |
39810.7 |
nM |
None |
| Homo sapiens |
Estrogen receptor alpha |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Gamma-aminobutyric acid receptor subunit alpha-1/alpha-2/beta-2/gamma-2 |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
HERG |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Histamine H3 receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Histone deacetylase 6 |
Inhibition |
-21.59 |
% |
10.6019/CHEMBL4808148 |
| Homo sapiens |
Histone deacetylase 6 |
Inhibition |
-3.43 |
% |
10.6019/CHEMBL4808148 |
| Homo sapiens |
Histone-lysine N-methyltransferase, H3 lysine-9 specific 3 |
Potency |
25.1 |
nM |
None |
| Homo sapiens |
Histone-lysine N-methyltransferase, H3 lysine-9 specific 3 |
Potency |
17782.8 |
nM |
None |
| Homo sapiens |
Histone-lysine N-methyltransferase, H3 lysine-9 specific 3 |
Potency |
19952.6 |
nM |
None |
| Homo sapiens |
Histone-lysine N-methyltransferase, H3 lysine-9 specific 3 |
Potency |
39810.7 |
nM |
None |
| Homo sapiens |
Histone-lysine N-methyltransferase, H3 lysine-9 specific 3 |
Potency |
44668.4 |
nM |
None |
| Homo sapiens |
Homo sapiens |
Activity |
0.73 |
% |
10.1016/j.ejmech.2009.11.034 |
| Homo sapiens |
Homo sapiens |
DILI_Concern |
nan |
None |
10.1016/j.drudis.2016.02.015 |
| Homo sapiens |
Homo sapiens |
DILI_severity_class |
3.0 |
None |
10.1016/j.drudis.2016.02.015 |
| Homo sapiens |
Hypoxia-inducible factor 1 alpha |
Potency |
1584.9 |
nM |
None |
| Homo sapiens |
MAP kinase ERK2 |
Potency |
5011.9 |
nM |
None |
| Homo sapiens |
Menin/Histone-lysine N-methyltransferase MLL |
Potency |
14125.4 |
nM |
None |
| Homo sapiens |
Monoamine oxidase A |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
M-phase phosphoprotein 8 |
Potency |
44668.4 |
nM |
None |
| Homo sapiens |
Mu opioid receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Muscarinic acetylcholine receptor M1 |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Muscarinic acetylcholine receptor M2 |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Norepinephrine transporter |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Phosphodiesterase 3A |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Phosphodiesterase 4A |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Plasma |
fCmax |
266.43 |
uM |
10.1124/dmd.111.040758 |
| Homo sapiens |
Prelamin-A/C |
Potency |
6309.6 |
nM |
None |
| Homo sapiens |
Progesterone receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Proton-coupled amino acid transporter 1 |
Ki |
4400000.0 |
nM |
10.1016/j.bmc.2011.08.058 |
| Homo sapiens |
Proton-coupled amino acid transporter 1 |
pKi |
-0.64 |
mM |
10.1016/j.bmc.2011.08.058 |
| Homo sapiens |
Regulator of G-protein signaling 4 |
Potency |
532.3 |
nM |
None |
| Homo sapiens |
Runt-related transcription factor 1/Core-binding factor subunit beta |
Potency |
707.9 |
nM |
None |
| Homo sapiens |
Serotonin 1a (5-HT1a) receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Serotonin 2b (5-HT2b) receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Serotonin transporter |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Survival motor neuron protein |
Potency |
14125.4 |
nM |
None |
| Homo sapiens |
Thrombin |
AC50 |
3000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Thromboxane A2 receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Thyroid stimulating hormone receptor |
Potency |
3981.1 |
nM |
None |
| Homo sapiens |
Tyrosyl-DNA phosphodiesterase 1 |
Potency |
18356.4 |
nM |
None |
| Homo sapiens |
Vascular endothelial growth factor receptor 2 |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Klebsiella pneumoniae |
Klebsiella pneumoniae |
Inhibition |
12.0 |
% |
10.6019/CHEMBL4513141 |
| Klebsiella pneumoniae |
Klebsiella pneumoniae |
MIC |
8.0 |
ug.mL-1 |
10.1021/jm00156a021 |
| Mus musculus |
Mus musculus |
Dose |
45.0 |
% |
10.1021/jm00175a002 |
| Mus musculus |
Mus musculus |
Dose |
64.0 |
% |
10.1021/jm00175a002 |
| Mus musculus |
Mus musculus |
ED50 |
1.25 |
mg.kg-1 |
10.1021/jm00050a001 |
| Mus musculus |
Mus musculus |
ED50 |
3.0 |
mg.kg-1 |
10.1021/jm00050a001 |
| Mycobacterium avium |
Mycobacterium avium |
GI |
15.0 |
% |
10.1016/j.bmcl.2011.11.114 |
| Mycobacterium avium |
Mycobacterium avium |
GI |
100.0 |
% |
10.1016/j.bmcl.2011.11.114 |
| Mycobacterium avium |
Mycobacterium avium |
GI |
nan |
None |
10.1016/j.bmc.2012.05.004 |
| Mycobacterium avium |
Mycobacterium avium |
MIC |
3.12 |
ug.mL-1 |
10.1016/j.ejmech.2017.06.005 |
| Mycobacterium tuberculosis |
Alanine racemase |
Inhibition |
10.0 |
% |
10.1021/ml400349n |
| Mycobacterium tuberculosis |
Alanine racemase |
Inhibition |
nan |
% |
10.1021/ml400349n |
| Mycobacterium tuberculosis |
D-alanylalanine synthetase |
Activity |
nan |
None |
10.1021/ml400349n |
| Mycobacterium tuberculosis |
D-alanylalanine synthetase |
Inhibition |
nan |
% |
10.1021/ml400349n |
| Mycobacterium tuberculosis |
Mycobacterium tuberculosis |
Activity |
nan |
None |
10.1021/jm100568q |
| Mycobacterium tuberculosis |
Mycobacterium tuberculosis |
Activity |
nan |
None |
10.1021/ml400349n |
| Mycobacterium tuberculosis |
Mycobacterium tuberculosis |
EC50 |
12470.0 |
nM |
10.1016/j.bmcl.2014.01.007 |
| Mycobacterium tuberculosis |
Mycobacterium tuberculosis |
EC50 |
23550.0 |
nM |
10.1016/j.bmcl.2012.12.069 |
| Mycobacterium tuberculosis |
Mycobacterium tuberculosis |
EC50 |
24760.0 |
nM |
10.1016/j.bmcl.2012.12.069 |
| Mycobacterium tuberculosis |
Mycobacterium tuberculosis |
EC90 |
13.49 |
uM |
10.1016/j.bmcl.2014.01.007 |
| Mycobacterium tuberculosis |
Mycobacterium tuberculosis |
EC90 |
26.38 |
uM |
10.1016/j.bmcl.2012.12.069 |
| Mycobacterium tuberculosis |
Mycobacterium tuberculosis |
EC90 |
28.01 |
uM |
10.1016/j.bmcl.2012.12.069 |
| Mycobacterium tuberculosis |
Mycobacterium tuberculosis |
GI |
50.0 |
% |
10.1016/j.bmc.2012.05.004 |
| Mycobacterium tuberculosis |
Mycobacterium tuberculosis |
GI |
50.0 |
% |
10.1016/j.bmcl.2011.11.114 |
| Mycobacterium tuberculosis |
Mycobacterium tuberculosis |
GI |
50.0 |
% |
10.1016/j.bmcl.2020.127351 |
| Mycobacterium tuberculosis |
Mycobacterium tuberculosis |
GI |
60.0 |
% |
10.1016/j.bmc.2012.05.004 |
| Mycobacterium tuberculosis |
Mycobacterium tuberculosis |
GI |
60.0 |
% |
10.1016/j.bmcl.2011.11.114 |
| Mycobacterium tuberculosis |
Mycobacterium tuberculosis |
GI |
67.0 |
% |
10.1016/j.bmcl.2020.127351 |
| Mycobacterium tuberculosis |
Mycobacterium tuberculosis |
GI |
71.0 |
% |
10.1016/j.bmcl.2020.127351 |
| Mycobacterium tuberculosis |
Mycobacterium tuberculosis |
GI |
80.0 |
% |
10.1016/j.bmc.2012.05.004 |
| Mycobacterium tuberculosis |
Mycobacterium tuberculosis |
GI |
80.0 |
% |
10.1016/j.bmcl.2011.11.114 |
| Mycobacterium tuberculosis |
Mycobacterium tuberculosis |
GI |
100.0 |
% |
10.1016/j.bmc.2012.05.004 |
| Mycobacterium tuberculosis |
Mycobacterium tuberculosis |
GI |
100.0 |
% |
10.1016/j.bmcl.2011.11.114 |
| Mycobacterium tuberculosis |
Mycobacterium tuberculosis |
GI |
nan |
None |
10.1016/j.bmc.2012.05.004 |
| Mycobacterium tuberculosis |
Mycobacterium tuberculosis |
IC50 |
12.47 |
ug.mL-1 |
10.1016/j.ejmech.2013.09.061 |
| Mycobacterium tuberculosis |
Mycobacterium tuberculosis |
IC50 |
12470.0 |
nM |
10.1016/j.bmc.2016.09.044 |
| Mycobacterium tuberculosis |
Mycobacterium tuberculosis |
IC50 |
12470.0 |
nM |
10.1016/j.bmcl.2017.05.050 |
| Mycobacterium tuberculosis |
Mycobacterium tuberculosis |
IC50 |
12470.0 |
nM |
10.1016/j.ejmech.2013.12.013 |
| Mycobacterium tuberculosis |
Mycobacterium tuberculosis |
IC50 |
12470.0 |
nM |
10.1016/j.ejmech.2014.08.009 |
| Mycobacterium tuberculosis |
Mycobacterium tuberculosis |
IC50 |
20800.0 |
nM |
10.1016/j.bmcl.2016.03.066 |
| Mycobacterium tuberculosis |
Mycobacterium tuberculosis |
IC50 |
20800.0 |
nM |
10.1016/j.ejmech.2017.11.035 |
| Mycobacterium tuberculosis |
Mycobacterium tuberculosis |
IC90 |
13.49 |
ug.mL-1 |
10.1016/j.ejmech.2013.09.061 |
| Mycobacterium tuberculosis |
Mycobacterium tuberculosis |
IC90 |
13490.0 |
nM |
10.1016/j.bmc.2016.09.044 |
| Mycobacterium tuberculosis |
Mycobacterium tuberculosis |
IC90 |
13490.0 |
nM |
10.1016/j.bmcl.2017.05.050 |
| Mycobacterium tuberculosis |
Mycobacterium tuberculosis |
IC90 |
13490.0 |
nM |
10.1016/j.ejmech.2013.12.013 |
| Mycobacterium tuberculosis |
Mycobacterium tuberculosis |
IC90 |
13490.0 |
nM |
10.1016/j.ejmech.2014.08.009 |
| Mycobacterium tuberculosis |
Mycobacterium tuberculosis |
IC90 |
33100.0 |
nM |
10.1016/j.bmcl.2016.03.066 |
| Mycobacterium tuberculosis |
Mycobacterium tuberculosis |
IC90 |
33100.0 |
nM |
10.1016/j.ejmech.2017.11.035 |
| Mycobacterium tuberculosis |
Mycobacterium tuberculosis |
Inhibition |
50.0 |
% |
10.1016/j.bmcl.2021.128261 |
| Mycobacterium tuberculosis |
Mycobacterium tuberculosis |
Inhibition |
50.0 |
% |
10.1021/jm100165w |
| Mycobacterium tuberculosis |
Mycobacterium tuberculosis |
Inhibition |
50.0 |
% |
10.1021/jm100568q |
| Mycobacterium tuberculosis |
Mycobacterium tuberculosis |
Inhibition |
51.0 |
% |
10.1016/j.ejmech.2013.09.061 |
| Mycobacterium tuberculosis |
Mycobacterium tuberculosis |
Inhibition |
67.0 |
% |
10.1016/j.bmcl.2021.128261 |
| Mycobacterium tuberculosis |
Mycobacterium tuberculosis |
Inhibition |
67.0 |
% |
10.1021/jm100568q |
| Mycobacterium tuberculosis |
Mycobacterium tuberculosis |
Inhibition |
71.0 |
% |
10.1016/j.bmcl.2021.128261 |
| Mycobacterium tuberculosis |
Mycobacterium tuberculosis |
Inhibition |
71.0 |
% |
10.1021/jm100568q |
| Mycobacterium tuberculosis |
Mycobacterium tuberculosis |
Inhibition |
80.0 |
% |
10.1021/jm100165w |
| Mycobacterium tuberculosis |
Mycobacterium tuberculosis |
Inhibition |
93.9 |
% |
10.1016/j.ejmech.2013.09.061 |
| Mycobacterium tuberculosis |
Mycobacterium tuberculosis |
Inhibition |
96.3 |
% |
10.1016/j.ejmech.2013.09.061 |
| Mycobacterium tuberculosis |
Mycobacterium tuberculosis |
Inhibition |
97.7 |
% |
10.1016/j.ejmech.2013.09.061 |
| Mycobacterium tuberculosis |
Mycobacterium tuberculosis |
Inhibition |
100.0 |
% |
10.1021/jm100165w |
| Mycobacterium tuberculosis |
Mycobacterium tuberculosis |
MIC |
3.12 |
ug.mL-1 |
10.1016/j.ejmech.2017.06.005 |
| Mycobacterium tuberculosis |
Mycobacterium tuberculosis |
MIC |
8.0 |
ug.mL-1 |
10.1128/aac.00661-10 |
| Mycobacterium tuberculosis |
Mycobacterium tuberculosis |
MIC |
12.5 |
ug.mL-1 |
10.1016/j.ejmech.2017.06.005 |
| Mycobacterium tuberculosis |
Mycobacterium tuberculosis |
MIC |
16.0 |
ug.mL-1 |
10.1128/aac.00661-10 |
| Mycobacterium tuberculosis |
Mycobacterium tuberculosis |
MIC |
50.0 |
ug.mL-1 |
10.1016/j.ejmech.2018.09.067 |
| Mycobacterium tuberculosis |
Mycobacterium tuberculosis |
MIC |
25000.0 |
nM |
10.1016/j.bmc.2016.09.044 |
| Mycobacterium tuberculosis |
Mycobacterium tuberculosis |
MIC |
25000.0 |
nM |
10.1016/j.bmcl.2017.05.050 |
| Mycobacterium tuberculosis |
Mycobacterium tuberculosis |
MIC |
25000.0 |
nM |
10.1016/j.ejmech.2014.08.009 |
| Mycobacterium tuberculosis |
Mycobacterium tuberculosis |
MIC |
50000.0 |
nM |
10.1016/j.bmcl.2016.03.066 |
| Mycobacterium tuberculosis |
Mycobacterium tuberculosis |
MIC |
50000.0 |
nM |
10.1016/j.ejmech.2017.11.035 |
| Mycobacterium tuberculosis |
Mycobacterium tuberculosis |
MIC |
60500.0 |
nM |
10.1128/aac.00055-06 |
| Mycobacterium tuberculosis |
Mycobacterium tuberculosis |
MIC |
63700.0 |
nM |
10.1128/aac.00055-06 |
| Mycobacterium tuberculosis |
Mycobacterium tuberculosis |
MIC |
100000.0 |
nM |
10.1016/j.bmcl.2012.12.069 |
| Mycobacterium tuberculosis |
Mycobacterium tuberculosis |
MIC |
120900.0 |
nM |
10.1016/j.bmcl.2019.02.019 |
| Mycobacterium tuberculosis |
Mycobacterium tuberculosis |
MIC |
124800.0 |
nM |
10.1128/aac.00055-06 |
| Mycobacterium tuberculosis |
Mycobacterium tuberculosis |
MIC |
128000.0 |
nM |
10.1128/aac.00055-06 |
| Mycobacterium tuberculosis |
Mycobacterium tuberculosis |
MIC |
157000.0 |
nM |
10.1021/acs.jmedchem.2c00227 |
| Mycobacterium tuberculosis |
Mycobacterium tuberculosis |
MIC |
167000.0 |
nM |
10.1016/j.bmcl.2019.02.019 |
| Mycobacterium tuberculosis |
Mycobacterium tuberculosis |
MIC |
196500.0 |
nM |
10.1016/j.bmcl.2019.02.019 |
| Mycobacterium tuberculosis |
Mycobacterium tuberculosis |
MIC |
241600.0 |
nM |
10.1016/j.bmcl.2019.02.019 |
| Mycobacterium tuberculosis |
Mycobacterium tuberculosis |
MIC |
245100.0 |
nM |
10.1016/j.bmcl.2019.02.019 |
| Mycobacterium tuberculosis |
Mycobacterium tuberculosis |
MIC50 |
1.0 |
ug.mL-1 |
10.1016/j.bmcl.2011.11.114 |
| Mycobacterium tuberculosis |
Mycobacterium tuberculosis |
MIC50 |
5.0 |
ug.mL-1 |
10.1016/j.bmc.2012.05.004 |
| Mycobacterium tuberculosis |
Mycobacterium tuberculosis |
MIC50 |
5.0 |
ug.mL-1 |
10.1016/j.bmcl.2011.11.114 |
| Mycobacterium tuberculosis |
Mycobacterium tuberculosis |
MIC50 |
5.0 |
ug.mL-1 |
10.1021/jm100165w |
| Mycobacterium tuberculosis |
Mycobacterium tuberculosis |
MIC50 |
5.0 |
ug.mL-1 |
10.1021/jm100568q |
| Mycobacterium tuberculosis |
Mycobacterium tuberculosis |
MIC50 |
5.1 |
ug.mL-1 |
10.1016/j.bmcl.2020.127351 |
| Mycobacterium tuberculosis |
Mycobacterium tuberculosis |
MIC50 |
5.1 |
ug.mL-1 |
10.1016/j.bmcl.2021.128261 |
| Mycobacterium tuberculosis |
Mycobacterium tuberculosis |
MIC50 |
5.2 |
ug.mL-1 |
10.1016/j.bmcl.2020.127351 |
| Mycobacterium tuberculosis |
Mycobacterium tuberculosis |
MIC50 |
5.2 |
ug.mL-1 |
10.1016/j.bmcl.2021.128261 |
| Mycobacterium tuberculosis |
Mycobacterium tuberculosis |
MIC90 |
4.8 |
ug.mL-1 |
10.1021/np400497f |
| Mycobacterium tuberculosis |
Mycobacterium tuberculosis |
MIC90 |
4.9 |
ug.mL-1 |
10.1021/np400497f |
| Mycobacterium tuberculosis |
Mycobacterium tuberculosis |
MIC90 |
5.0 |
ug.mL-1 |
10.1021/np400497f |
| Mycobacterium tuberculosis |
Mycobacterium tuberculosis |
MIC90 |
6.02 |
ug.mL-1 |
10.1021/np400497f |
| Mycobacterium tuberculosis |
Mycobacterium tuberculosis |
MIC90 |
10.2 |
ug.mL-1 |
10.1021/np400497f |
| Mycobacterium tuberculosis |
Mycobacterium tuberculosis |
MIC90 |
25000.0 |
nM |
10.1016/j.bmcl.2014.01.007 |
| Mycobacterium tuberculosis |
Mycobacterium tuberculosis |
MIC90 |
25000.0 |
nM |
10.1016/j.ejmech.2013.09.061 |
| Mycobacterium tuberculosis |
Mycobacterium tuberculosis |
MIC90 |
37100.0 |
nM |
10.1016/j.bmcl.2019.02.019 |
| Mycobacterium tuberculosis |
Mycobacterium tuberculosis |
MIC90 |
245000.0 |
nM |
10.1016/j.ejmech.2016.07.039 |
| Mycobacterium tuberculosis |
Mycobacterium tuberculosis |
Ratio |
2.0 |
None |
10.1021/ml400349n |
| Mycobacterium tuberculosis H37Rv |
Mycobacterium tuberculosis H37Rv |
Stability |
10.0 |
% |
10.1021/ml400349n |
| Mycolicibacterium fortuitum |
Mycolicibacterium fortuitum |
MIC |
3.12 |
ug.mL-1 |
10.1016/j.ejmech.2017.06.005 |
| Mycolicibacterium smegmatis |
Mycolicibacterium smegmatis |
MIC |
3.12 |
ug.mL-1 |
10.1016/j.ejmech.2017.06.005 |
| Mycolicibacterium smegmatis |
Mycolicibacterium smegmatis |
MIC |
105.0 |
ug.mL-1 |
10.1016/j.ejmech.2016.12.060 |
| Plasmodium falciparum |
Plasmodium falciparum |
Potency |
657.3 |
nM |
None |
| Plasmodium falciparum |
Plasmodium falciparum |
Potency |
9528.3 |
nM |
None |
| Providencia alcalifaciens |
Providencia alcalifaciens |
MIC |
8.0 |
ug.mL-1 |
10.1021/jm00156a021 |
| Providencia rettgeri |
Providencia rettgeri |
MIC |
128.0 |
ug.mL-1 |
10.1021/jm00156a021 |
| Pseudomonas aeruginosa |
Pseudomonas aeruginosa |
Inhibition |
60.23 |
% |
10.6019/CHEMBL4513141 |
| Pseudomonas aeruginosa |
Pseudomonas aeruginosa |
MIC |
64.0 |
ug.mL-1 |
10.1021/jm00156a021 |
| Pseudomonas aeruginosa |
Pseudomonas aeruginosa |
MIC |
128.0 |
ug.mL-1 |
10.1021/jm00156a021 |
| Pseudomonas aeruginosa |
Pseudomonas aeruginosa |
MIC |
128.0 |
ug.mL-1 |
10.1128/aac.00845-07 |
| Rattus norvegicus |
Bile salt export pump |
IC50 |
1000000.0 |
nM |
10.1124/dmd.111.040758 |
| Rattus norvegicus |
Glutamate NMDA receptor |
Activity |
nan |
None |
10.1021/jm900363q |
| Rattus norvegicus |
Glutamate NMDA receptor |
EC50 |
2950.0 |
nM |
10.1016/s0960-894x(99)00194-8 |
| Rattus norvegicus |
Glutamate NMDA receptor |
IC50 |
2300.0 |
nM |
10.1021/jm00050a001 |
| Rattus norvegicus |
Glutamate [NMDA] receptor subunit epsilon 3 |
EC50 |
18100.0 |
nM |
10.1021/jm00050a001 |
| Rattus norvegicus |
Glutamate (NMDA) receptor subunit zeta 1 |
IC50 |
7370.0 |
nM |
10.1016/s0960-894x(99)00194-8 |
| Rattus norvegicus |
Muscarinic acetylcholine receptor M1 |
Potency |
28183.8 |
nM |
None |
| Rattus norvegicus |
Thioredoxin reductase 1, cytoplasmic |
Potency |
23.8 |
nM |
None |
| Serratia liquefaciens |
Serratia liquefaciens |
MIC |
8.0 |
ug.mL-1 |
10.1021/jm00156a021 |
| Serratia marcescens |
Serratia marcescens |
MIC |
128.0 |
ug.mL-1 |
10.1021/jm00156a021 |
| Severe acute respiratory syndrome coronavirus 2 |
Replicase polyprotein 1ab |
Inhibition |
23.75 |
% |
10.6019/CHEMBL4495564 |
| Severe acute respiratory syndrome coronavirus 2 |
Replicase polyprotein 1ab |
Inhibition |
29.49 |
% |
10.6019/CHEMBL4495564 |
| Severe acute respiratory syndrome coronavirus 2 |
SARS-CoV-2 |
IC50 |
19952.62 |
nM |
10.6019/CHEMBL4651402 |
| Severe acute respiratory syndrome coronavirus 2 |
SARS-CoV-2 |
IC50 |
20000.0 |
nM |
10.6019/CHEMBL4651402 |
| Severe acute respiratory syndrome coronavirus 2 |
SARS-CoV-2 |
Inhibition |
-2.21 |
% |
10.21203/rs.3.rs-23951/v1 |
| Severe acute respiratory syndrome coronavirus 2 |
SARS-CoV-2 |
Inhibition |
-0.09 |
% |
10.6019/CHEMBL4495565 |
| Severe acute respiratory syndrome coronavirus 2 |
SARS-CoV-2 |
Inhibition |
0.17 |
% |
10.6019/CHEMBL4495565 |
| Severe acute respiratory syndrome coronavirus 2 |
SARS-CoV-2 |
Inhibition index |
1.427 |
None |
10.1101/2020.04.03.023846 |
| Staphylococcus aureus |
Staphylococcus aureus |
Activity |
nan |
None |
10.1128/aac.00166-09 |
| Staphylococcus aureus |
Staphylococcus aureus |
Diameter |
36.0 |
nm |
10.1021/jm00175a002 |
| Staphylococcus aureus |
Staphylococcus aureus |
ED50 |
2.2 |
ug |
10.1128/aac.00200-09 |
| Staphylococcus aureus |
Staphylococcus aureus |
ED50 |
5.4 |
ug |
10.1128/aac.00200-09 |
| Staphylococcus aureus |
Staphylococcus aureus |
ED50 |
40.0 |
ug |
10.1128/aac.00200-09 |
| Staphylococcus aureus |
Staphylococcus aureus |
FC |
3.13 |
None |
10.1128/aac.00273-08 |
| Staphylococcus aureus |
Staphylococcus aureus |
FC |
3.41 |
None |
10.1128/aac.00273-08 |
| Staphylococcus aureus |
Staphylococcus aureus |
FC |
4.08 |
None |
10.1128/aac.00273-08 |
| Staphylococcus aureus |
Staphylococcus aureus |
FC |
4.6 |
None |
10.1128/aac.00273-08 |
| Staphylococcus aureus |
Staphylococcus aureus |
FC |
15.63 |
None |
10.1128/aac.00273-08 |
| Staphylococcus aureus |
Staphylococcus aureus |
Inhibition |
14.71 |
% |
10.6019/CHEMBL4513141 |
| Staphylococcus aureus |
Staphylococcus aureus |
MIC |
0.75 |
ug.mL-1 |
10.1128/aac.01099-08 |
| Staphylococcus aureus |
Staphylococcus aureus |
MIC |
1.0 |
ug.mL-1 |
10.1128/aac.00273-08 |
| Staphylococcus aureus |
Staphylococcus aureus |
MIC |
1.0 |
ug.mL-1 |
10.1128/aac.01099-08 |
| Staphylococcus aureus |
Staphylococcus aureus |
MIC |
8.0 |
ug.mL-1 |
10.1128/aac.01099-08 |
| Staphylococcus aureus |
Staphylococcus aureus |
MIC |
12.5 |
ug.mL-1 |
10.1128/aac.00200-09 |
| Staphylococcus aureus |
Staphylococcus aureus |
MIC |
25.0 |
ug.mL-1 |
10.1128/aac.00200-09 |
| Staphylococcus aureus |
Staphylococcus aureus |
MIC |
32.0 |
ug.mL-1 |
10.1016/j.bmcl.2007.01.015 |
| Staphylococcus aureus |
Staphylococcus aureus |
MIC |
32.0 |
ug.mL-1 |
10.1128/aac.00166-09 |
| Staphylococcus aureus |
Staphylococcus aureus |
MIC |
32.0 |
ug.mL-1 |
10.1128/aac.00845-07 |
| Staphylococcus aureus |
Staphylococcus aureus |
MIC |
50.0 |
ug.mL-1 |
10.1128/aac.00200-09 |
| Staphylococcus aureus |
Staphylococcus aureus |
MIC |
50.0 |
ug.mL-1 |
10.1128/aac.00504-07 |
| Staphylococcus aureus |
Staphylococcus aureus |
MIC |
64.0 |
ug.mL-1 |
10.1128/aac.00166-09 |
| Staphylococcus aureus |
Staphylococcus aureus |
MIC |
64.0 |
ug.mL-1 |
10.1128/aac.00209-07 |
| Staphylococcus aureus |
Staphylococcus aureus |
MIC |
64.0 |
ug.mL-1 |
10.1128/aac.00845-07 |
| Staphylococcus aureus |
Staphylococcus aureus |
MIC |
100.0 |
ug.mL-1 |
10.1128/aac.00200-09 |
| Staphylococcus aureus |
Staphylococcus aureus |
MIC |
128.0 |
ug.mL-1 |
10.1128/aac.00209-07 |
| Staphylococcus aureus |
Staphylococcus aureus |
MIC |
313000.0 |
nM |
10.1016/j.ejmech.2018.09.067 |
| Staphylococcus epidermidis (strain ATCC 35984 / RP62A) |
UDP-N-acetylmuramoyl-tripeptide--D-alanyl-D-alanine ligase |
IC50 |
300000.0 |
nM |
10.1021/jm00117a017 |
| Streptomyces acidiscabies |
Streptomyces acidiscabies |
DIZ |
nan |
None |
10.1584/jpestics.28.183 |
| Streptomyces alboniger |
Streptomyces alboniger |
DIZ |
nan |
None |
10.1584/jpestics.28.183 |
| Streptomyces scabiei |
Streptomyces scabiei |
Activity |
44.0 |
mm |
10.1584/jpestics.28.183 |
| Streptomyces scabiei |
Streptomyces scabiei |
DIZ |
nan |
None |
10.1584/jpestics.28.183 |
| Streptomyces scabiei |
Streptomyces scabiei |
IZ |
24.0 |
mm |
10.1584/jpestics.28.183 |
| Trypanosoma brucei |
6-phospho-1-fructokinase |
Potency |
33807.8 |
nM |
None |
| None |
ADMET |
log10(%HIA +10) |
1.919 |
None |
10.1016/j.ejmech.2010.11.005 |
| None |
Hepatotoxicity |
HepSE_bilirubinemia |
0.0 |
None |
10.1371/journal.pcbi.1002310 |
| None |
Hepatotoxicity |
HepSE_cholecystitis |
0.0 |
None |
10.1371/journal.pcbi.1002310 |
| None |
Hepatotoxicity |
HepSE_cholelithiasis |
0.0 |
None |
10.1371/journal.pcbi.1002310 |
| None |
Hepatotoxicity |
HepSE_cirrhosis |
0.0 |
None |
10.1371/journal.pcbi.1002310 |
| None |
Hepatotoxicity |
HepSE_Combined Scores |
1.0 |
None |
10.1371/journal.pcbi.1002310 |
| None |
Hepatotoxicity |
HepSE_elevated liver function tests |
0.0 |
None |
10.1371/journal.pcbi.1002310 |
| None |
Hepatotoxicity |
HepSE_hepatic failure |
0.0 |
None |
10.1371/journal.pcbi.1002310 |
| None |
Hepatotoxicity |
HepSE_hepatic necrosis |
0.0 |
None |
10.1371/journal.pcbi.1002310 |
| None |
Hepatotoxicity |
HepSE_hepatitis |
0.0 |
None |
10.1371/journal.pcbi.1002310 |
| None |
Hepatotoxicity |
HepSE_hepatomegaly |
0.0 |
None |
10.1371/journal.pcbi.1002310 |
| None |
Hepatotoxicity |
HepSE_jaundice |
0.0 |
None |
10.1371/journal.pcbi.1002310 |
| None |
Hepatotoxicity |
HepSE_liver disease |
1.0 |
None |
10.1371/journal.pcbi.1002310 |
| None |
Hepatotoxicity |
HepSE_liver fatty |
0.0 |
None |
10.1371/journal.pcbi.1002310 |
| None |
Hepatotoxicity |
HepSE_liver function tests abnormal |
0.0 |
None |
10.1371/journal.pcbi.1002310 |
| None |
NON-PROTEIN TARGET |
Hepatotoxicity (acute) |
5.4 |
% |
10.1016/s0399-8320(04)95062-2 |
| None |
NON-PROTEIN TARGET |
Hepatotoxicity (animal toxicity known) |
nan |
None |
10.1016/s0399-8320(04)95062-2 |
| None |
NON-PROTEIN TARGET |
Hepatotoxicity (benign tumour) |
0.0 |
None |
10.1016/s0399-8320(04)95062-2 |
| None |
NON-PROTEIN TARGET |
Hepatotoxicity (granulomatous hepatitis) |
0.0 |
None |
10.1016/s0399-8320(04)95062-2 |
| None |
NON-PROTEIN TARGET |
Hepatotoxicity (mechanism) |
nan |
None |
10.1016/s0399-8320(04)95062-2 |
| None |
NON-PROTEIN TARGET |
Hepatotoxicity (moderate) |
3.0 |
None |
10.1016/s0399-8320(04)95062-2 |
| None |
NON-PROTEIN TARGET |
Hepatotoxicity (moderate) |
13.0 |
% |
10.1016/s0399-8320(04)95062-2 |
| None |
NON-PROTEIN TARGET |
Hepatotoxicity (time to onset) |
nan |
None |
10.1016/s0399-8320(04)95062-2 |
| None |
NON-PROTEIN TARGET |
MIC |
128.0 |
ug.mL-1 |
10.1021/jm00156a021 |
| None |
NON-PROTEIN TARGET |
Potency |
0.7 |
nM |
None |
| None |
NON-PROTEIN TARGET |
Potency |
5.3 |
nM |
None |
| None |
NON-PROTEIN TARGET |
Potency |
6.7 |
nM |
None |
| None |
NON-PROTEIN TARGET |
Potency |
16.8 |
nM |
None |
| None |
NON-PROTEIN TARGET |
Potency |
236.9 |
nM |
None |
| None |
NON-PROTEIN TARGET |
Potency |
530.5 |
nM |
None |
| None |
NON-PROTEIN TARGET |
Potency |
17782.8 |
nM |
None |
| None |
No relevant target |
CLogP |
nan |
None |
10.1021/jm00129a016 |
| None |
Unchecked |
Ac50 |
0.5623 |
uM |
None |
| None |
Unchecked |
Ac50 |
1.0 |
uM |
None |
| None |
Unchecked |
Ac50 |
1.585 |
uM |
None |
| None |
Unchecked |
Ac50 |
3.162 |
uM |
None |
| None |
Unchecked |
AC50 |
570.0 |
nM |
None |
| None |
Unchecked |
AC50 |
1000.0 |
nM |
None |
| None |
Unchecked |
AC50 |
1584.9 |
nM |
None |
| None |
Unchecked |
AC50 |
3162.3 |
nM |
None |
| None |
Unchecked |
Activity |
0.12 |
mAU |
10.1128/aac.00166-09 |
| None |
Unchecked |
Activity |
0.33 |
mAU |
10.1128/aac.00166-09 |
| None |
Unchecked |
Activity |
30.0 |
mAU |
10.1128/aac.00166-09 |
| None |
Unchecked |
Activity |
50.0 |
% |
10.1021/jm900363q |
| None |
Unchecked |
Activity |
100.0 |
mAU |
10.1128/aac.00166-09 |
| None |
Unchecked |
Activity |
146.0 |
mAU |
10.1128/aac.00166-09 |
| None |
Unchecked |
Activity |
181.0 |
mAU |
10.1128/aac.00166-09 |
| None |
Unchecked |
Activity |
2255.0 |
mAU |
10.1128/aac.00166-09 |
| None |
Unchecked |
Activity |
5087.0 |
mAU |
10.1128/aac.00166-09 |
| None |
Unchecked |
EC50 |
6309.57 |
nM |
10.1021/jm900363q |
| None |
Unchecked |
Hepatotoxicity (acute) |
2.0 |
None |
10.1016/s0399-8320(04)95062-2 |
| None |
Unchecked |
Hepatotoxicity (association with vascular disease) |
0.0 |
None |
10.1016/s0399-8320(04)95062-2 |
| None |
Unchecked |
Hepatotoxicity (choleostasis) |
0.0 |
None |
10.1016/s0399-8320(04)95062-2 |
| None |
Unchecked |
Hepatotoxicity (chronic liver disease) |
0.0 |
None |
10.1016/s0399-8320(04)95062-2 |
| None |
Unchecked |
Hepatotoxicity (cirrhosis) |
0.0 |
None |
10.1016/s0399-8320(04)95062-2 |
| None |
Unchecked |
Hepatotoxicity (comment) |
nan |
None |
10.1016/s0399-8320(04)95062-2 |
| None |
Unchecked |
Hepatotoxicity (cytolytic) |
2.0 |
None |
10.1016/s0399-8320(04)95062-2 |
| None |
Unchecked |
Hepatotoxicity (malignant tumour) |
0.0 |
None |
10.1016/s0399-8320(04)95062-2 |
| None |
Unchecked |
Hepatotoxicity (severe hepatitis) |
1.0 |
None |
10.1016/s0399-8320(04)95062-2 |
| None |
Unchecked |
Hepatotoxicity (steatosis) |
0.0 |
None |
10.1016/s0399-8320(04)95062-2 |
| None |
Unchecked |
Hepatotoxicity (successful reintroduction) |
nan |
None |
10.1016/s0399-8320(04)95062-2 |
| None |
Unchecked |
IC50 |
250000.0 |
nM |
10.1021/jm00121a030 |
| None |
Unchecked |
IC50 |
314000.0 |
nM |
10.1016/j.bmcl.2007.01.015 |
| None |
Unchecked |
Inhibition |
3.0 |
% |
10.1016/j.bmc.2007.12.040 |
| None |
Unchecked |
Inhibition |
nan |
% |
10.1038/nchembio873 |
| None |
Unchecked |
Ki |
22000.0 |
nM |
10.1021/jm800726b |
| None |
Unchecked |
Ki |
25000.0 |
nM |
10.1016/j.ejmech.2018.09.067 |
| None |
Unchecked |
Ki |
27000.0 |
nM |
10.1016/j.bmc.2008.02.046 |
| None |
Unchecked |
Ki |
250000.0 |
nM |
10.1021/jm00128a033 |
| None |
Unchecked |
ME |
122.0 |
% |
10.1016/s0960-894x(99)00194-8 |
| None |
Unchecked |
Potency |
1995.3 |
nM |
None |
| None |
Unchecked |
Ratio |
30.3 |
None |
10.1128/aac.00845-07 |
| None |
Unchecked |
Selectivity Index |
17.0 |
None |
10.1021/np400497f |